Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients
Clinical trial NCT05320757 · COMPLETED
Trial details
- NCT number
- NCT05320757
- Sponsor
- The University of Hong Kong
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2025-05-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.